Portal de investigación
Toward a Noninvasive, Label-Free Screening Method for Determining Spore Inoculum Quality of Penicillium chrysogenum Using Raman Spectroscopy
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Wieland, K
- Ehgartner, D
- Ramer, G
- Koch, C
- Ofner, J
- Herwig, C
- Lendl, B
Grupos
Abstract
We report on a label-free, noninvasive method for determination of spore inoculum quality of Penicillium chrysogenum prior to cultivation/germination. Raman microspectroscopy providing direct, molecule-specific information was used to extract information on the viability state of spores sampled directly from the spore inoculum. Based on the recorded Raman spectra, a supervised classification method was established for classification between living and dead spores and thus determining spore inoculum quality for optimized process control. A fast and simple sample preparation method consisting of one single dilution step was employed to eliminate interfering signals from the matrix and to achieve isolation of single spores on the sample carrier (CaF2). Aiming to avoid any influence of the killing procedure in the Raman spectrum of the spore, spores were considered naturally dead after more than one year of storage time. Fluorescence staining was used as reference method. A partial least squares discriminant analysis classifier was trained with Raman spectra of 258 living and dead spores (178 spectra for calibration, 80 spectra for validation). The classifier showed good performance when being applied to a 1 mu L droplet taken from a 1:1 mixture of living and dead spores. Of 135 recorded spectra, 51% were assigned to living spores while 49% were identified as dead spores by the classifier. The results obtained in this work are a fundamental step towards developing an automated, label-free, and noninvasive screening method for assessing spore inoculum quality.
Datos de la publicación
- ISSN/ISSNe:
- 0003-7028, 1943-3530
- Tipo:
- Article
- Páginas:
- 2661-2669
- PubMed:
- 28776414
- Factor de Impacto:
- 0,489 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
APPLIED SPECTROSCOPY SAGE PUBLICATIONS INC
Citas Recibidas en Web of Science: 3
Documentos
- No hay documentos
Filiaciones
Keywords
- Raman microspectroscopy; classification; spore inoculum quality; Penicillium chrysogenum; partial least squares discriminant analysis; PLS-DA; process optimization
Proyectos y Estudios Clínicos
UTILIDAD DEL TRATAMIENTO TOCOLITICO DE MANTENIMIENTO EN EL MANEJO DE LA AMENAZA DE PARTO PREMATURO (APP)
Investigador Principal: MÁXIMO VENTO TORRES
EC11-246 . 2012
MULTICENTER, RANDOMIZED, BLINDED CLINICAL STUDY COMPARING EARLY USE OF TOTAL BODY MODERATE HYPOTHERMIA PLUS TOPIRAMATE OR PLACEBO IN ASPHYXIATED NEWBORN INFANTS EVOLVING TO MODERATE-TO-SEVERE HYPOXIC ISCHEMIC ENCEPHALOPATHY
Investigador Principal: MÁXIMO VENTO TORRES
EC11-244 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012
EFECTO DE LA MODULACION DEL FACTOR INDUCIBLE POR HIPOXIA (HIF) SOBRE LA DEGENERACION RETINIANA EN RETINOSIS PIGMENTARIA
Investigador Principal: REGINA RODRIGO NICOLÁS
PI12/00481 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
RED DE SALUD MATERNO INFANTIL Y DEL DESARROLLO
Investigador Principal: MÁXIMO VENTO TORRES
RD12/0026/0012 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
DAÑO OXIDATIVO Y METILACIÓN DEL ADN Y ACTIVIDAD DE LAS ENZIMAS REPARADORAS Y SU FRECUENCIA MUTAGÉNICA EN PREMATUROS SEGÚN LA CARGA DE OXÍGENO RECIBIDA EN LA REANIMACIÓN
Investigador Principal: MÁXIMO VENTO TORRES
PI14/00443 . INSTITUTO DE SALUD CARLOS III . 2015
ALBINO. EFFECT OF ALLOPURINOL IN ADDITION TO HYPOTHERMIA FOR HYPOXIC-ISCHEMIC BRAIN INJURY ON NEUROCOGNITIVE OUTCOME.
Investigador Principal: MÁXIMO VENTO TORRES
667224 . COMISION EUROPEA . 2016
MINIMAL INVASIVE BIOMARKERS FOR THE PERSONALIZED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY (HIE). (CONTRATO)
Investigador Principal: JULIA KULIGOWSKI
MS16/00034 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2017
RED DE SALUD MATERNO-INFANTIL Y DEL DESARROLLO.
Investigador Principal: MÁXIMO VENTO TORRES
RD16/0022/0001 . INSTITUTO DE SALUD CARLOS III . 2017
MINIMAL INVASIVE BIOMARKERS FOR THE PERSONALIZED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY (HIE). (PROYECTO)
Investigador Principal: JULIA KULIGOWSKI
CP16/00034 . INSTITUTO DE SALUD CARLOS III . 2017
ENSAYO CLÍNICO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO POR PLACEBO, COMPARANDO EL USO DE LA HIPOTERMIA CORPORAL TOTAL MODERADA PRECOZ CON TOPIRAMATO O CON PLACEBO EN RECIÉN NACIDOS ASFIXIADOS EVOLUCIONANDO A ENCEFALOPATÍA HIPÓXICO ISQUÉMICA MODERADA A SEVERA.
Investigador Principal: MÁXIMO VENTO TORRES
1645-CI-058 (HYPOTOP) . 2013
Cita
Wieland K,KULIGOWSKI J,Ehgartner D,Ramer G,Koch C,Ofner J,Herwig C,Lendl B. Toward a Noninvasive, Label-Free Screening Method for Determining Spore Inoculum Quality of Penicillium chrysogenum Using Raman Spectroscopy. Appl Spectrosc. 2017. 71. (12):p. 2661-2669. IF:1,642. (3).